Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 26 min ago
PreprintAll rights reservedbioRxiv

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

14 more authors
  1. 1Sorbonne University

Related

  1. Complement activation in immune thrombotic thrombocytopenic purpura: Possible amplifier and potential therapeutic opportunity.
    Massimo Cugno, Spero R Cataland, Bernhard Lämmle
    HemaSpherePeer-reviewedCC BYFull textImmunologyEurope PMC
  2. Reprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity
    Luigi Cerbone, Alessia Garau, Andrea Balossino +14
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  3. Targeting the IRE1α/XBP1 pathway in type 2 diabetes mellitus: from ER stress signaling to therapeutic opportunity.
    Olabisi Tajudeen Obafemi, Ademola Olabode Ayeleso, Bidemi Emmanuel Ekundayo +4
    Molecular biology reportsPeer-reviewedCC BYFull text1 citedCell biologyEurope PMC
  4. Macrophage immunometabolism in osteoporosis: an emerging regulatory axis linking metabolic–polarization coupling to therapeutic targets
    Lian Weng, Qianli Yuan, Taizhou Mo +3
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  5. Identification of Peripheral Blood mIR-128-3p Molecular Signature in Children with Autism Spectrum Disorder
    TN Popov, SD Minchev, TI Vachev
    Balkan journal of medical genetics : BJMGPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
BibTeX
@misc{binvignat2026regulatory,
  title = {{A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease}},
  author = {M. Binvignat and F. Martina and F. Pitoiset and A. Roux and R. Lorenzon and P. Hodara and P. Barennes and H. Vantomme and M. Sastre and S. Hassler and C. Ribet and A. Courties and V. Mhanna and P. Stys and L. Adda and V. Diderot and E. Vicaut and C. Aheng and N. Coatnoan and A. Six and N. Tchitchek and M. Rosenzwajg and F. Berenbaum and D. Klatzmann and J. Sellam and E. Mariotti-Ferrandiz},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.21.753213},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.21.753213v1},
}
RIS
TY  - UNPB
TI  - A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease
AU  - M. Binvignat
AU  - F. Martina
AU  - F. Pitoiset
AU  - A. Roux
AU  - R. Lorenzon
AU  - P. Hodara
AU  - P. Barennes
AU  - H. Vantomme
AU  - M. Sastre
AU  - S. Hassler
AU  - C. Ribet
AU  - A. Courties
AU  - V. Mhanna
AU  - P. Stys
AU  - L. Adda
AU  - V. Diderot
AU  - E. Vicaut
AU  - C. Aheng
AU  - N. Coatnoan
AU  - A. Six
AU  - N. Tchitchek
AU  - M. Rosenzwajg
AU  - F. Berenbaum
AU  - D. Klatzmann
AU  - J. Sellam
AU  - E. Mariotti-Ferrandiz
PY  - 2026
DA  - 2026/09/21
PB  - bioRxiv
DO  - 10.64898/2026.09.21.753213
UR  - https://www.biorxiv.org/content/10.64898/2026.09.21.753213v1
ER  -